Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a80cbaaeee718664126e579cf4e41c2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 |
filingDate |
2007-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1b1afe59f653240a124bbfcf6264220 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0dbcc7f4b4d5333f54cf6c92b6eee7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0843fcbd22665ace432430efe12f5efe |
publicationDate |
2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2532849-T3 |
titleOfInvention |
Treatment with melatonin agonist |
abstract |
Use of (1 R-trans) -N - [[2- (2,3-dihydro-4-benzofuranyl) cyclopropyl] methyl] -propanamide (MA-1) for the preparation of a pharmaceutical composition for the treatment of a disorder of circadian rhythm or a sleep disorder, the pharmaceutical composition being formulated to orally administer MA-1 to the subject suffering from such disorder in an amount of about 20 mg to about 50 mg daily. |
priorityDate |
2006-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |